Related Experiment Videos
Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal
L R Prieto1, C K Foreman, J P Cheatham
1Department of Pediatric Cardiology, Cleveland Clinic Foundation, Ohio 44120, USA.
The American Journal of Cardiology
|December 1, 1996
Abstract:
Of 31 patients who underwent transcatheter atrial septal defect occlusion with the Bard Clamshell Septal Umbrella, only 1 had a clinically significant residual atrial septal defect at a mean follow-up of 41 months. All patients were asymptomatic despite the occurrence of device arm fractures in 84% of these patients.